The Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs
This study has been completed.
Sponsor:
New York Presbyterian Hospital
Information provided by:
New York Presbyterian Hospital
ClinicalTrials.gov Identifier:
NCT00212459
First received: September 13, 2005
Last updated: March 26, 2013
Last verified: May 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.
| Condition | Intervention |
|---|---|
|
Hemophilia A Hemophilia B |
Behavioral: Counseling Behavioral: Control |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | A Prospective Randomized Pilot Study on the Effect of Patient Counseling on Adolescent Hemophilia Patient Compliance With Bleeding Logs |
Resource links provided by NLM:
Genetics Home Reference related topics:
hemophilia
MedlinePlus related topics:
Hemophilia
U.S. FDA Resources
Further study details as provided by New York Presbyterian Hospital:
Primary Outcome Measures:
- Study and control groups will be compared with respect to the % of bleeds reported to the HTC and % of recommended therapy recorded in bleeding logs after a 6 month period [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Study and control groups will be compared with respect to time between initiation of target joint bleeding and the identification and treatment of such by HTC personnel [ Time Frame: 6 months ] [ Designated as safety issue: No ]
- Clotting factor consumption and the cost of therapy in each group will be compared [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Enrollment: | 14 |
| Study Start Date: | May 2005 |
| Study Completion Date: | April 2008 |
| Primary Completion Date: | February 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 1
Patients are contacted every two weeks after initial counseling to discuss completion of bleeding records.
|
Behavioral: Counseling
Patients are contacted every two weeks after initial counseling to discuss the completion of bleeding records.
|
|
Active Comparator: 2
After the initial counseling with regards to bleeding records, there are no more contacts made with the control patients.
|
Behavioral: Control
No more contacts are made with control patients after the initial counseling session.
|
Detailed Description:
The study will see if counselling adolescents with severe or moderate Hemophilia A or B results in increased compliance in the maintenance of bleeding logs.To do this subjects will be randomized into a control group and a group who will receive consistent counselling by a pharmacist about their bleeding logs.
The aims of the study are:
- To provide a new method of bleeding and treatment documentation in the home setting (logs) to adolescent subjects with Hemophilia A or B
- To counsel these subjects about adherence to their treatment regimen prescribed by physician and the importance of keeping accurate documentation of each bleeding episode and its treatment.
- To improve maintenance of logs, to allow for 1) assessment of bleeding frequency and treatment efficacy and 2) early detection of target joint bleeding and the potential need for prophylactic factor replacement.
Eligibility| Ages Eligible for Study: | 12 Years to 20 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Ages 12 through 20
- Severe or moderate Hemophilia A or B
- Self-infusing or transitioning to self infusion in the home setting
- Already assigned responsibility of monitoring bleeding logs
Exclusion Criteria:
- Not meeting inclusion criteria
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00212459
Locations
| United States, New York | |
| NY Presbyterian Hospital | |
| New York, New York, United States, 10021 | |
Sponsors and Collaborators
New York Presbyterian Hospital
Investigators
| Principal Investigator: | Donna M DiMichele, MD | Weill Medical College of Cornell University |
More Information
No publications provided
| Responsible Party: | Donna DiMichele, MD, New York Presbyterian Hospital |
| ClinicalTrials.gov Identifier: | NCT00212459 History of Changes |
| Other Study ID Numbers: | Bleeding Logs |
| Study First Received: | September 13, 2005 |
| Last Updated: | March 26, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by New York Presbyterian Hospital:
|
Bleeding logs Factor Infusions |
Additional relevant MeSH terms:
|
Hemophilia B Hemophilia A Hemorrhage Blood Coagulation Disorders, Inherited Blood Coagulation Disorders Hematologic Diseases |
Coagulation Protein Disorders Hemorrhagic Disorders Genetic Diseases, Inborn Genetic Diseases, X-Linked Pathologic Processes |
ClinicalTrials.gov processed this record on June 18, 2013